Company Filing History:
Years Active: 2020
Title: Innovations in Spinal Fusion: The Contributions of Monica Alvisi
Introduction
Monica Alvisi is a notable inventor based in Zurich, Switzerland. She has made significant contributions to the field of spinal fusion through her innovative pharmaceutical formulations. Her work is particularly focused on enhancing the effectiveness of spinal fusion methods, which are critical for patients suffering from spinal disorders.
Latest Patents
Monica Alvisi holds a patent for a pharmaceutical formulation designed for use in spinal fusion. This formulation includes a composition for forming a matrix, a kit comprising the composition, and a pharmaceutical product that can be obtained from the formulation. The invention also features an interbody spinal fusion cage that contains the pharmaceutical formulation or the pharmaceutical product. The composition consists of at least two matrix material precursor components that can crosslink to form the matrix under specific conditions. Additionally, it incorporates a bioactive factor, specifically PTH or a PTH fusion peptide, which is biologically active in stimulating bone formation between vertebrae and supporting spinal fusion.
Career Highlights
Monica Alvisi has established herself as a key figure in the field of biomedical innovation. Her work at Kuros Biosurgery AG has allowed her to focus on developing advanced solutions for spinal fusion, contributing to improved patient outcomes. With her expertise, she has been able to bridge the gap between pharmaceutical science and surgical applications.
Collaborations
Monica collaborates with esteemed colleagues such as Jason Schense and Silke Mark. Their combined efforts in research and development have further propelled advancements in spinal fusion technologies.
Conclusion
Monica Alvisi's contributions to spinal fusion through her innovative pharmaceutical formulations highlight the importance of research and collaboration in the medical field. Her work not only advances scientific knowledge but also has the potential to significantly improve patient care.